Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors
© 2016 Informa UK Limited, trading as Taylor & Francis Group. Objective: Current chemotherapy treatments available for treating high-grade brain tumors, Temozolomide (TMZ) or Bevacizumab (BEV), not only have specific anti-tumor mechanisms, but also have an effect on mitochondria. However, effe...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Journal |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84978422190&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/56162 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Chiang Mai University |